Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (191-200 of 645) with videos related to

Pageof 65
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|June 2, 2025
Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-AnalysisPaola Rogliani, Gian Marco Manzetti, Mario Cazzola, et al.
Expert Opinion on Investigational Drugs|June 26, 2023
Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approvalLuigino Calzetta, Elena Pistocchini, Alfredo Chetta, et al.
British Journal of Haematology|July 25, 2003
Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin productionMario Cazzola, Yves Beguin, Janusz Kloczko, et al.
The European Respiratory Journal|April 13, 2012
Emerging anti-inflammatory strategies for COPDMario Cazzola, Clive P Page, Luigino Calzetta, et al.
Pulmonary Pharmacology & Therapeutics|January 15, 2005
Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthmaAlessandro Vatrella, Antonio Ponticiello, Girolamo Pelaia, et al.
Respiratory Medicine|November 7, 2009
Combining triple therapy and pulmonary rehabilitation in patients with advanced COPD: a pilot studyFranco Pasqua, Gianluca Biscione, Girolmina Crigna, et al.
Drugs & Aging|June 14, 2023
Pharmacotherapies in Older Adults with COPD: Challenges and OpportunitiesMaria Gabriella Matera, Nicola A Hanania, Mauro Maniscalco, et al.
Expert Review of Anti-Infective Therapy|March 7, 2025
The ongoing challenge of prevention of pertussis in infants: what's new in 2024?Maria Gabriella Matera, Carlo Capristo, Vito de Novellis, et al.
Journal of Inflammation Research|December 18, 2025
Established and Emerging Biological Therapies for the Treatment of Comorbid Asthma and Chronic Obstructive Pulmonary DiseaseMario Cazzola, Maria Gabriella Matera, Nicola A Hanania, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 4, 2013
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluationMario Cazzola, Luigino Calzetta, Clive P Page, et al.
Pageof 65

Showing results (191-200 of 645) with videos related to

Sort By:
Pageof 65
International Journal of Chronic Obstructive Pulmonary Disease|June 2, 2025
Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-AnalysisPaola Rogliani, Gian Marco Manzetti, Mario Cazzola, et al.
Expert Opinion on Investigational Drugs|June 26, 2023
Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approvalLuigino Calzetta, Elena Pistocchini, Alfredo Chetta, et al.
British Journal of Haematology|July 25, 2003
Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin productionMario Cazzola, Yves Beguin, Janusz Kloczko, et al.
The European Respiratory Journal|April 13, 2012
Emerging anti-inflammatory strategies for COPDMario Cazzola, Clive P Page, Luigino Calzetta, et al.
Pulmonary Pharmacology & Therapeutics|January 15, 2005
Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthmaAlessandro Vatrella, Antonio Ponticiello, Girolamo Pelaia, et al.
Respiratory Medicine|November 7, 2009
Combining triple therapy and pulmonary rehabilitation in patients with advanced COPD: a pilot studyFranco Pasqua, Gianluca Biscione, Girolmina Crigna, et al.
Drugs & Aging|June 14, 2023
Pharmacotherapies in Older Adults with COPD: Challenges and OpportunitiesMaria Gabriella Matera, Nicola A Hanania, Mauro Maniscalco, et al.
Expert Review of Anti-Infective Therapy|March 7, 2025
The ongoing challenge of prevention of pertussis in infants: what's new in 2024?Maria Gabriella Matera, Carlo Capristo, Vito de Novellis, et al.
Journal of Inflammation Research|December 18, 2025
Established and Emerging Biological Therapies for the Treatment of Comorbid Asthma and Chronic Obstructive Pulmonary DiseaseMario Cazzola, Maria Gabriella Matera, Nicola A Hanania, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 4, 2013
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluationMario Cazzola, Luigino Calzetta, Clive P Page, et al.
Pageof 65